A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Sodium Nitroprusside (NIPRIDE RTU)

Vasodilator class · 11 generic manufacturers · 14 ANDAs filed at FDA.

First FDA approval2017-03-20
Generic availableYes · 11 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Sodium Nitroprusside used for?

Sodium Nitroprusside is a Vasodilator medication tracked in Medicare Part D.

Is there a generic for Sodium Nitroprusside?

Yes. 14 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Sodium Nitroprusside?

NADAC pricing data not currently available for this drug.

Is Sodium Nitroprusside on the FDA shortage list?

No. Sodium Nitroprusside is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Vasodilator3 alternatives in D1
01
Nitric Oxide
Brand: GENOSYL
Lowest NADAC
2Generic mfrs
CY24 Part D spend
Compare →
02
Noxivent 102
Vasodilator
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Ulspira
Vasodilator
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.